Polpharma Biologics integrates Dutch based subsidiary, Bioceros, to offer the complete spectrum of services from discovery to commercial supply.
Gdansk, Poland and Utrecht, The Netherlands 13th July 2020. In 2016, Polpharma Biologics acquired Dutch based Biocero…
On Demand Webinar: Looking to develop a high quality, high titer manufacturing cell line?
We have developed our SPOT™ technology alongside our proprietary CHO cell line to increase the cell line specific pro…
All hands on deck! We all fight with COVID-19
The current situation caused by COVID-19 concerns us all. We had decided to help because we care. That’s why we have…
First subjects in ph III study with PB006 (proposed Biosimilar to Natalizumab) have been randomized.
Our phase III clinical trial (PB006-03-01) entered into the stage when first patients were treated with study medicat…
32nd International Symposium on Preparative and Process Chromatography in Baltimore
We participated in the 32nd International Symposium on Preparative and Process Chromatography in Baltimore.
Launching of the 4th edition of the Career Laboratory!
We are starting recruitment for the 4th edition of our Career Laboratory internship program.
Meet us at BIO-Europe Spring in Vienna!
Polpharma Biologics participates in 13th annual BIO-Europe Spring conference in Vienna (Austria).
Inauguration of the second edition of the BIO Academy (BIO Akademia)
Polpharma Biologics invests in the practical education of its employees in the field of biotechnology.
Join us at BIO-Europe Conference
Polpharma Biologics participates in 24th BIO-Europe conference in Copenhagen (Denmark) where we present our fully int…
Meet us at CPHI Worldwide
CPhI Worldwide is the biggest event with over 28 years’ experience of bringing the pharmaceutical world together.